Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
340 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 331 (97%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
50 (15%) |
|
Overdue reports |
2 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE INJECTION | 900MG | SOLUTION SOLUTION | Resolved | 2022-05-06 | 2022-06-21 | 160191 |
| 0.9% SODIUM CHLORIDE INJECTION | 900MG | SOLUTION SOLUTION | Resolved | 2022-06-15 | 2022-06-21 | 162651 |
| 0.9% SODIUM CHLORIDE INJECTION | 900MG | SOLUTION SOLUTION | Resolved | 2022-10-02 | 2022-12-05 | 170890 |
| 0.9% SODIUM CHLORIDE INJECTION | 900MG | SOLUTION SOLUTION | Resolved | 2024-09-03 | 2024-10-09 | 236464 |
| 0.9% SODIUM CHLORIDE INJECTION | 900MG | SOLUTION SOLUTION | Resolved | 2024-10-25 | 2025-04-08 | 241158 |
| 5% DEXTROSE INJECTION | 50MG | SOLUTION | Resolved | 2024-09-03 | 2024-09-28 | 236461 |
| 5% DEXTROSE INJECTION | 50MG | SOLUTION | Resolved | 2025-01-10 | 2025-02-10 | 247474 |
| ACYCLOVIR SODIUM INJECTION | 50MG | SOLUTION | Resolved | 2018-09-14 | 2018-10-16 | 61472 |
| ACYCLOVIR SODIUM INJECTION | 50MG | SOLUTION | Resolved | 2020-04-07 | 2020-08-15 | 111364 |
| ACYCLOVIR SODIUM INJECTION | 50MG | SOLUTION | Resolved | 2020-04-07 | 2020-08-17 | 111367 |
| ACYCLOVIR SODIUM INJECTION | 50MG | SOLUTION | Resolved | 2020-08-17 | 2021-01-06 | 122380 |
| ACYCLOVIR SODIUM INJECTION | 50MG | SOLUTION | Resolved | 2020-08-17 | 2021-01-12 | 122384 |
| ACYCLOVIR SODIUM INJECTION | 50MG | SOLUTION | Resolved | 2024-01-09 | 2024-01-31 | 215434 |
| ADENOSINE INJECTION | 3MG | SOLUTION | Resolved | 2017-11-13 | 2018-02-01 | 29048 |
| ADENOSINE INJECTION | 3MG | SOLUTION | Resolved | 2021-09-02 | 2021-11-04 | 145130 |
| ADENOSINE INJECTION | 3MG | SOLUTION | Resolved | 2022-05-02 | 2022-06-27 | 159829 |
| ADENOSINE INJECTION | 3MG | SOLUTION | Resolved | 2022-11-03 | 2023-01-02 | 173478 |
| ADENOSINE INJECTION | 3MG | SOLUTION | Actual shortage | 2025-03-11 | 2025-05-04 | 252332 |
| ADENOSINE INJECTION | 3MG | SOLUTION | Resolved | 2022-05-02 | 2023-01-02 | 159832 |
| ADENOSINE INJECTION | 3MG | SOLUTION | Resolved | 2020-02-13 | 2020-11-05 | 105902 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2